The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > COLUMN
COLUMN
- Maurer's Healthcare Insight (95)
May 19, 2008
- Maurer's Healthcare Insight (94)
March 10, 2008
- Maurer's Healthcare Insight (93)
February 18, 2008
- Maurer's Healthcare Insight (92)
January 21, 2008
- Maurer's Healthcare Insight (91)
December 24, 2007
- Maurer's Healthcare Insight (90)
November 5, 2007
- Maurer's Healthcare Insight (89)
October 8, 2007
- Maurer's Healthcare Insight (88)
August 6, 2007
- Maurer's Healthcare Insight (87) Japan Is (Is Not) an Attractive Market Part 2 P. Reed Maurer
June 4, 2007
- Maurer's Healthcare Insight (86)
May 28, 2007
- Maurer's Healthcare Insight (85)
April 16, 2007
- Maurer's Healthcare Insight (84)
March 26, 2007
- Japan's Most Admired Pharma Companies in 2006 P. Reed Maurer
March 12, 2007
- Maurer's Healthcare Insight (83)
February 19, 2007
- 2006: When the Pendulum Swung P. Reed Maurer
January 8, 2007
- Maurer's Healthcare Insight (82)／Questions from the Floor P. Reed Maurer
December 18, 2006
- Maurer's Healthcare Insight (81)
November 20, 2006
- Maurer's Healthcare Insight (80)
October 23, 2006
- Maurer's Healthcare Insight (79) Back from the Saddle P. Reed Maurer
September 25, 2006
- Maurer's Healthcare Insight (78) Infinite Value of a Good Boss P. Reed Maurer
August 28, 2006
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…